Discover and read the best of Twitter Threads about #CRC
Most recents (24)
@TumorBoardTues @shafiarahman_ @RischZack @MPishvaian @ColonCancerCoal @colontown @coloncancermike @GlobalCRC 2/6 #TumorBoardTuesday
Thurs Case🎀
#mCRC & #EGFR tx:
✅Anti-EGFR useful in RAS/RAF WT; debate re: timing vs anti-VEGF
✅Pt centered discussion including SEs 🗝️
✅Emerging data: EGFR re-tx, using ctDNA to guide
📚@shafiarahman_ @RischZack’s thread:
threadreaderapp.com/thread/1638330…
Thurs Case🎀
#mCRC & #EGFR tx:
✅Anti-EGFR useful in RAS/RAF WT; debate re: timing vs anti-VEGF
✅Pt centered discussion including SEs 🗝️
✅Emerging data: EGFR re-tx, using ctDNA to guide
📚@shafiarahman_ @RischZack’s thread:
threadreaderapp.com/thread/1638330…
@TumorBoardTues @shafiarahman_ @RischZack @MPishvaian @ColonCancerCoal @colontown @coloncancermike @GlobalCRC 3/6 #TumorBoardTuesday
🎥 TBT in a vid- Part 1:
@shafiarahman_ 's approach: pt eligible for EGFR-directed tx in #metastatic #CRC
🔹RAS/RAF WT- more important than side
🔹Bev or pan 1L? Trend toward pan, but is 🗝️actually that pt gets anti-EGFR in tx, 🚫necessarily 1L?
🎥 TBT in a vid- Part 1:
@shafiarahman_ 's approach: pt eligible for EGFR-directed tx in #metastatic #CRC
🔹RAS/RAF WT- more important than side
🔹Bev or pan 1L? Trend toward pan, but is 🗝️actually that pt gets anti-EGFR in tx, 🚫necessarily 1L?
@TumorBoardTues @shafiarahman_ @RischZack @MPishvaian @ColonCancerCoal @colontown @coloncancermike @GlobalCRC 4/6 #TumorBoardTuesday
🎥 TBT in a vid- Part 2:
@shafiarahman_ gives us a preview of what might be coming in #EGFR directed tx in #mCRC
🔹Re-challenge based on ctDNA clearance of resistant clones; pts w resistance to EGFRi benefit later as the tumor evolves again
🔹New combos!
🎥 TBT in a vid- Part 2:
@shafiarahman_ gives us a preview of what might be coming in #EGFR directed tx in #mCRC
🔹Re-challenge based on ctDNA clearance of resistant clones; pts w resistance to EGFRi benefit later as the tumor evolves again
🔹New combos!
@TumorBoardTues @MPishvaian @JohnEbbenMDPhD @CCAlliance 1/22 #TumorBoardTuesday #ColonCancerAwarenessMonth #OncTwitter @shafiarahman_
62 yo 👨🏼🦳 asymptomatic
🔦 Screening colonoscopy - sigmoid mass
🔬Biopsy + for pMMR/MSS adenocarcinoma
🩻Staging CT + for unresectable liver mets
🤨What first line systemic treatment would you choose?
62 yo 👨🏼🦳 asymptomatic
🔦 Screening colonoscopy - sigmoid mass
🔬Biopsy + for pMMR/MSS adenocarcinoma
🩻Staging CT + for unresectable liver mets
🤨What first line systemic treatment would you choose?
@TumorBoardTues @MPishvaian @JohnEbbenMDPhD @CCAlliance @shafiarahman_ 2/22 #TumorBoardTuesday @MPishvaian @JohnEbbenMDPhD #CRCAwarenessMonth
👨🏼🦳started on first line FOLFOX
🧪NGS testing
KRAS/BRAF WT
TMB low
ERBB2 negative
ATM mutation
👨🏼🦳started on first line FOLFOX
🧪NGS testing
KRAS/BRAF WT
TMB low
ERBB2 negative
ATM mutation
@TumorBoardTues @MPishvaian @JohnEbbenMDPhD @CCAlliance @shafiarahman_ 3/22 #TumorBoardTuesday #GI23 #CRCAwareness
👩🏻🏫Mini tweetorial 1👨🏻🏫
↩️Left side tumors more common:
BRAF WT
KRAS WT
HER2 amp
↪️Right side tumors enriched for
BRAF V600E mutation
KRAS Mut
MSI-H
📚@ASCO
👩🏻🏫Mini tweetorial 1👨🏻🏫
↩️Left side tumors more common:
BRAF WT
KRAS WT
HER2 amp
↪️Right side tumors enriched for
BRAF V600E mutation
KRAS Mut
MSI-H
📚@ASCO
@TumorBoardTues @brian_rini @JVentoMD @MPishvaian @Uromigos @JoshLangMD @renalandurology @UroDocAsh 2/5 #TumorBoardTuesday
Thurs Case🎀
Take🏠msgs:
✅ Pembro ONLY approved adj IO in RCC
✅ 3 recent trials w IO failure: nivo/ipi, atezo & periop nivo
✅ Must balance risks vs benefits- shared decision-making 🗝️
📚@brian_rini @JVentoMD’s thread:
threadreaderapp.com/thread/1635792…
Thurs Case🎀
Take🏠msgs:
✅ Pembro ONLY approved adj IO in RCC
✅ 3 recent trials w IO failure: nivo/ipi, atezo & periop nivo
✅ Must balance risks vs benefits- shared decision-making 🗝️
📚@brian_rini @JVentoMD’s thread:
threadreaderapp.com/thread/1635792…
@TumorBoardTues @brian_rini @JVentoMD @MPishvaian @Uromigos @JoshLangMD @renalandurology @UroDocAsh 3/5 #TumorBoardTuesday
Thurs Case🎀
🎥 TBT in a video
High risk #RCC, pembro= DFS advantage, but w cost- Grade 3 AEs= 32%. High risk #RCC defined by:
🔹Stage II w sarcomatoid features
🔹Stage III+
🔹Regional LN+/M1 disease
Quick overview of adj IO decision making:
Thurs Case🎀
🎥 TBT in a video
High risk #RCC, pembro= DFS advantage, but w cost- Grade 3 AEs= 32%. High risk #RCC defined by:
🔹Stage II w sarcomatoid features
🔹Stage III+
🔹Regional LN+/M1 disease
Quick overview of adj IO decision making:
@TumorBoardTues @brian_rini @JVentoMD @MPishvaian @Uromigos @JoshLangMD @renalandurology @UroDocAsh 4/5 #TumorBoardTuesday
Thursday Case🎀
📷 TBT in an image
Nomograms, including ASSURE from @FoxChaseCancer can provide addtl context re: risk of recurrence–but remember:
⭐️Every patient is an individual!
Our guide to help lead discussions w pts re: risks/benefits of adj IO:
Thursday Case🎀
📷 TBT in an image
Nomograms, including ASSURE from @FoxChaseCancer can provide addtl context re: risk of recurrence–but remember:
⭐️Every patient is an individual!
Our guide to help lead discussions w pts re: risks/benefits of adj IO:
#FIFAWorldCup Here are today's four fixtures:
#HRV vs #BEL (1500 GMT)
#CAN vs #MAR (1500 GMT)
#JPN vs #ESP (1900 GMT)
#CRC vs #GER (1900 GMT)
Follow our #Qatar2022 coverage here:👇
#HRV vs #BEL (1500 GMT)
#CAN vs #MAR (1500 GMT)
#JPN vs #ESP (1900 GMT)
#CRC vs #GER (1900 GMT)
Follow our #Qatar2022 coverage here:👇
#FIFAWorldCup full-time score:
#CAN 1 - 2 #MAR
Goalscorers:
CAN: (OG) Aguerd
MAR: Ziyech, en-Nesyri
#Qatar2022
#CAN 1 - 2 #MAR
Goalscorers:
CAN: (OG) Aguerd
MAR: Ziyech, en-Nesyri
#Qatar2022
Going into the last match, here's what each team in Group E needs. #FIFAWorldCup #ESP #JPN #CRC #GER #GroupE
A win by ESP, JPN, CRC sees respective team through to the knockout.
GER must win, and need some help.
ESP can lose and still go through. Others are out if they lose.
A win by ESP, JPN, CRC sees respective team through to the knockout.
GER must win, and need some help.
ESP can lose and still go through. Others are out if they lose.
ESP 🇪🇸
1. win or draw vs JPN
2. loss => probably OK, it can be complicated
We'll get to the complications below.
1. win or draw vs JPN
2. loss => probably OK, it can be complicated
We'll get to the complications below.
JPN 🇯🇵
1. win
2. draw + CRC-GER draw or GER victory by exactly 1 goal. GER gets the tiebreaker (GD) by winning by 2 or more goals.
1. win
2. draw + CRC-GER draw or GER victory by exactly 1 goal. GER gets the tiebreaker (GD) by winning by 2 or more goals.
Spain's starting XI passing sonars
Costa Rica's starting XI passing sonars
¡El último boleto a #Qatar2022!
Costa Rica #CRC 🇨🇷 y Nueva Zelanda #NZL 🇳🇿 se enfrentan en Doha 🇶🇦 por un lugar en el mundial.
CONCACAF 🆚 OFC
Costa Rica #CRC 🇨🇷 🆚 Nueva Zelanda #NZL 🇳🇿
Costa Rica #CRC 🇨🇷 y Nueva Zelanda #NZL 🇳🇿 se enfrentan en Doha 🇶🇦 por un lugar en el mundial.
CONCACAF 🆚 OFC
Costa Rica #CRC 🇨🇷 🆚 Nueva Zelanda #NZL 🇳🇿
Costa Rica #CRC 🇨🇷
Debutó en una #FIFAWC en #Italy1990 🇮🇹, donde compartió el Grupo C con Escocia #SCO 🏴 (V), Brasil #BRA 🇧🇷 (D) y Suecia #SWE 🇸🇪 (V). Sumó 4 puntos y clasificó a los Octavos de Final, donde cayó ante Checoslovaquia #TCH.
Debutó en una #FIFAWC en #Italy1990 🇮🇹, donde compartió el Grupo C con Escocia #SCO 🏴 (V), Brasil #BRA 🇧🇷 (D) y Suecia #SWE 🇸🇪 (V). Sumó 4 puntos y clasificó a los Octavos de Final, donde cayó ante Checoslovaquia #TCH.
Participaciones en #FIFAWC: 5️⃣
Su primera participación en un mundial: #Italy1990 🇮🇹.
Su última participación en un mundial: #Russia2018 🇷🇺.
Mejor Participación: Cuartos de Final en #Brazil2014 🇧🇷.
Su primera participación en un mundial: #Italy1990 🇮🇹.
Su última participación en un mundial: #Russia2018 🇷🇺.
Mejor Participación: Cuartos de Final en #Brazil2014 🇧🇷.
Selecciones de CONMEBOL en Repechajes para la Copa del Mundo #FIFAWC.
Hasta el día de hoy, se han jugado 10 repechajes para una Copa del Mundo en los que haya participado una selección de CONMEBOL.
¿Qué selecciones ya jugaron un repechaje? ¿Cómo les fue? ¿Rivales? ¿Cuándo?
Hasta el día de hoy, se han jugado 10 repechajes para una Copa del Mundo en los que haya participado una selección de CONMEBOL.
¿Qué selecciones ya jugaron un repechaje? ¿Cómo les fue? ¿Rivales? ¿Cuándo?
¡La última ronda de las #Eliminatorias al Mundial de #Qatar2022 arrancó el día de hoy!
La lucha de los últimos 3 cupos al mundial. 🔥
• 1 Boleto CONMEBOL 🆚 AFC
• 1 Boleto CONCACAF 🆚 OFC
• 1 Boleto Europeo.
La lucha de los últimos 3 cupos al mundial. 🔥
• 1 Boleto CONMEBOL 🆚 AFC
• 1 Boleto CONCACAF 🆚 OFC
• 1 Boleto Europeo.
En un emotivo regreso, Ucrania #UKR 🇺🇦 dejó fuera a Escocia #SCO 🏴 y se enfrentará a Gales #WAL 🏴 en la final por el último boleto europeo a #Qatar2022.
❎ #SCO 🏴 no juega un mundial desde #France1998.
☑️ #UKR 🇺🇦 (2006) y #WAL 🏴 (1958) buscan jugar su segundo mundial.
❎ #SCO 🏴 no juega un mundial desde #France1998.
☑️ #UKR 🇺🇦 (2006) y #WAL 🏴 (1958) buscan jugar su segundo mundial.
¡Las #EuropeanQualifiers camino a #Qatar2022 llegaron a su final y el último boleto fue para Gales 🏴!
☑️ Jugará su segunda Copa del Mundo.
¡Bienvenidos a #Qatar2022, @FAWales!
☑️ Jugará su segunda Copa del Mundo.
¡Bienvenidos a #Qatar2022, @FAWales!
1/12 #TumorBoardTuesday
🔬🧬Discussion on #ColonCancer and BRAFv600E disease w dMMR led by @FlavioRochaMD
➡️Here is this week's Thurs Case🎀
👉👉 Don’t forget to pick up🆓 #CME credit by answering 2 quick ❓
ALL CME 🔗: integrityce.com/tbt
Now…we’re off to the races!
🔬🧬Discussion on #ColonCancer and BRAFv600E disease w dMMR led by @FlavioRochaMD
➡️Here is this week's Thurs Case🎀
👉👉 Don’t forget to pick up🆓 #CME credit by answering 2 quick ❓
ALL CME 🔗: integrityce.com/tbt
Now…we’re off to the races!
2/11 #TumorBoardTuesday
Thurs Case🎀
Take🏠messages:
#CRC 🚫one disease!
✅Diff 🧬subtypes that define tx sensitivity
✅BRAFv600E is bad–but may be ⬆️sensitive to IO w MLH1 meth
✅Neoadj tx: 🦊FOXTROT= poss benefit, depends on subgroup
✅Keynote177: IO= way to go in dMMR!
Thurs Case🎀
Take🏠messages:
#CRC 🚫one disease!
✅Diff 🧬subtypes that define tx sensitivity
✅BRAFv600E is bad–but may be ⬆️sensitive to IO w MLH1 meth
✅Neoadj tx: 🦊FOXTROT= poss benefit, depends on subgroup
✅Keynote177: IO= way to go in dMMR!
3/12 #TumorBoardTuesday
Thurs Case🎀
Take🏠messages (cont’d):
✅ATOMIC will help answer ❓chemo/IO combo upfront is best in dMMR and BRAFv600E
✅POLEM trial also looking at adjuv IO in dMMR @shafiarahman_
📚We captured the discussion in this moment: twitter.com/i/events/15212…
Thurs Case🎀
Take🏠messages (cont’d):
✅ATOMIC will help answer ❓chemo/IO combo upfront is best in dMMR and BRAFv600E
✅POLEM trial also looking at adjuv IO in dMMR @shafiarahman_
📚We captured the discussion in this moment: twitter.com/i/events/15212…
😳🤯The hour flew by & none of us noticed!!
🙏🏽 @FogacciJoao for bringing the 🇧🇷 flair to #TumorBoardTuesday & #GastricCancer!!
🏆Remember your🆓CME
Look for Case Wrap Up🎀 04/28/22
📅Mark your calendar for 05/10/22 8pm ET when @FlavioRochaMD joins our #VirtualTumorBoard!!
🙏🏽 @FogacciJoao for bringing the 🇧🇷 flair to #TumorBoardTuesday & #GastricCancer!!
🏆Remember your🆓CME
Look for Case Wrap Up🎀 04/28/22
📅Mark your calendar for 05/10/22 8pm ET when @FlavioRochaMD joins our #VirtualTumorBoard!!
Remember #TumorBoardTuesday education goes beyond Twitter - we offer 🆓 CME!!
Pick up your🏆#CME & NOW #MOC(‼️) by answering quick questions regarding a case similar to @FogacciJoao’s‼️
🔗ALL CME: integrityce.com/tbt
🔗 post rationale: bit.ly/3kcIXdv
🇧🇷🎁🇧🇷
Pick up your🏆#CME & NOW #MOC(‼️) by answering quick questions regarding a case similar to @FogacciJoao’s‼️
🔗ALL CME: integrityce.com/tbt
🔗 post rationale: bit.ly/3kcIXdv
🇧🇷🎁🇧🇷
#PostTest Q1️⃣ #CME #TumorBoardTuesday @MPishvaian
🤔Now that @FogacciJoao schooled us through updates on immunotherapy for #GastricCancer, how would you answer these 2 quick ❓
🧬 Which are potentially useful immunotherapy biomarkers in gastric cancer?
🤔Now that @FogacciJoao schooled us through updates on immunotherapy for #GastricCancer, how would you answer these 2 quick ❓
🧬 Which are potentially useful immunotherapy biomarkers in gastric cancer?
#TBTWebinar is back ‼️
🥼 @MPishvaian @BreastCancerMD1 @Latinamd @BenWestphalen
#CME🔗 bit.ly/3vdXBb4
Pretest 👉 bit.ly/3rYNZir
Claim credit 👉 bit.ly/3ljVVXM
Supported by AstraZeneca Pharmaceuticals & Daiichi Sankyo, Inc
twitter.com/i/broadcasts/1…
🥼 @MPishvaian @BreastCancerMD1 @Latinamd @BenWestphalen
#CME🔗 bit.ly/3vdXBb4
Pretest 👉 bit.ly/3rYNZir
Claim credit 👉 bit.ly/3ljVVXM
Supported by AstraZeneca Pharmaceuticals & Daiichi Sankyo, Inc
twitter.com/i/broadcasts/1…
#TumorBoardTuesday HER2 #TBTWebinar 🔑
➡️HER2 activity requires receptor dimerization
✅HER1 = EGFR
✅HER3, HER4
➡️HER2 is frequently overexpressed in multiple cancers
✅Protein⬆️due to gene🧬 amplification
✅Constitutive activation due to activating🧬mutation
➡️HER2 activity requires receptor dimerization
✅HER1 = EGFR
✅HER3, HER4
➡️HER2 is frequently overexpressed in multiple cancers
✅Protein⬆️due to gene🧬 amplification
✅Constitutive activation due to activating🧬mutation
#TumorBoardTuesday HER2 #TBTWebinar 🔑
➡️HER2 (ERBB2) alterations occur in multiple cancer types
✅Breast Ca 25%
✅Gastric Ca 22%
✅GE jxn Ca 32%
✅CRC 5%
✅Lung Ca 6 to 30%
✅Biliary Ca 5 to 20%
🤔There is some disease specificity re: overexpression vs activating🧬mutation
➡️HER2 (ERBB2) alterations occur in multiple cancer types
✅Breast Ca 25%
✅Gastric Ca 22%
✅GE jxn Ca 32%
✅CRC 5%
✅Lung Ca 6 to 30%
✅Biliary Ca 5 to 20%
🤔There is some disease specificity re: overexpression vs activating🧬mutation
@rebelliousgut @MondayNightIBD @southasianIBD @ibdesis @Empoweringpts9 @DCharabaty @crohnsbabble @LivingWithUmeed @vkckiranpullela @TheMaveilousGut @dunung_ruchita 1/ I'm Tina from 🇺🇸 co-founder of Team @ibdesis. We are proud to lead #PatientExperience on @MondayNightIBD to discuss specific aspects of #SouthAsianIBD experience. We hope to improve care & reduce disparities in our community around the 🌍 thru @southasianIBD. #MondayNightIBD
@rebelliousgut @MondayNightIBD @southasianIBD @ibdesis @Empoweringpts9 @DCharabaty @crohnsbabble @LivingWithUmeed @vkckiranpullela @TheMaveilousGut @dunung_ruchita 2/ Even though my dad suffered from #Crohns, when I presented with #IBS #constipation, #GERD, joint pains & eye issues as a child, no one made the connection or escalated it to a gastroenterologist. #MondayNightIBD #SouthAsianIBD
@rebelliousgut @MondayNightIBD @southasianIBD @ibdesis @Empoweringpts9 @DCharabaty @crohnsbabble @LivingWithUmeed @vkckiranpullela @TheMaveilousGut @dunung_ruchita 3/ When my dad passed from #CRC, my family went into poverty & couldn't afford health insurance. Though I was symptomatic as a child, I didn't have a #colonoscopy until 22 when I got my 1st job. That's when I received my very delayed #IBD diagnosis. #MondayNightIBD #SouthAsianIBD
Good Morning #GImedTwitter
🌅🌄🌇Whether you are waking up in San Francisco…..or not (Curse you COVID-19😡)
🧑🏫Get ready for 3 packed days of presentations at #GI22
And to get the🧠started, we are going to share our
Top 10 Targeted Therapy Abstracts🎯
#TumorBoardTuesday
🌅🌄🌇Whether you are waking up in San Francisco…..or not (Curse you COVID-19😡)
🧑🏫Get ready for 3 packed days of presentations at #GI22
And to get the🧠started, we are going to share our
Top 10 Targeted Therapy Abstracts🎯
#TumorBoardTuesday
#TumorBoardTuesday
1⃣/
Once again HER2🎯💊is everywhere #GI22
👉The DESTINY trials have been👍4⃣T-DXd
✅DESTINY-CRC01
➡️T Yoshino, et al "RAPID" Abs 119
⏩53 "Group A" HER2+ RASWT CRC pts
⏩ORR 45%, mOS 15.5 mos
👍Even with prior HER2 Tx
😨But GR>=3 AEs in 65% of pts, 9% ILD
1⃣/
Once again HER2🎯💊is everywhere #GI22
👉The DESTINY trials have been👍4⃣T-DXd
✅DESTINY-CRC01
➡️T Yoshino, et al "RAPID" Abs 119
⏩53 "Group A" HER2+ RASWT CRC pts
⏩ORR 45%, mOS 15.5 mos
👍Even with prior HER2 Tx
😨But GR>=3 AEs in 65% of pts, 9% ILD
#TumorBoardTuesday #GI22
2⃣/
✅DESTINY-Gastric 01
➡️K Yamaguchi, et al "RAPID" Abs 242
⏩Randomized Ph II trial of >=2nd line💊
👉T-DXd vs. Physician’s choice (PC) which was Iri or Paclitaxel
⏩mOS 12.5 v 8.9 mos
⏩ORR 51% vs 14%
😨But Grade >= 3 AEs were 86% vs 57%
2⃣/
✅DESTINY-Gastric 01
➡️K Yamaguchi, et al "RAPID" Abs 242
⏩Randomized Ph II trial of >=2nd line💊
👉T-DXd vs. Physician’s choice (PC) which was Iri or Paclitaxel
⏩mOS 12.5 v 8.9 mos
⏩ORR 51% vs 14%
😨But Grade >= 3 AEs were 86% vs 57%
Pls join us in welcoming @JohnEbbenMDPhD to #TumorBoardTuesday!! 🎊
Dr Ebben is an onc fellow from WI, interested in🧬med & immunotherapy. He’ll also debate🧀curds & the best🍦custard in WI! He’ll be assisting with case wrap up🎀
We’re excited to have him!! #TBTFellow 1/17
Dr Ebben is an onc fellow from WI, interested in🧬med & immunotherapy. He’ll also debate🧀curds & the best🍦custard in WI! He’ll be assisting with case wrap up🎀
We’re excited to have him!! #TBTFellow 1/17
2/17 #TumorBoardTuesday Thursday Case🎀(08/24/21)
Bringing #ctDNA to bear to improve pts🙌🏽 @pashtoonkasi shows us how we can♻️ 🎯therapies to extend survival.
We go deep -🔬molecular biology➡️clinical trials➡️pt case.
👉🏽Don’t forget🆓#CME credit: bit.ly/3B9i6Wd
Bringing #ctDNA to bear to improve pts🙌🏽 @pashtoonkasi shows us how we can♻️ 🎯therapies to extend survival.
We go deep -🔬molecular biology➡️clinical trials➡️pt case.
👉🏽Don’t forget🆓#CME credit: bit.ly/3B9i6Wd
3/17 #TumorBoardTuesday Thursday Case🎀(08/24/21)
📚We captured as much of @pashtoonkasi's discussion as we could in this moment:
#ColorectalCancer #CRC #OncTwitter
twitter.com/i/events/14288…
📚We captured as much of @pashtoonkasi's discussion as we could in this moment:
#ColorectalCancer #CRC #OncTwitter
twitter.com/i/events/14288…
El día de ayer durante la final de #bmxfreestyle los atletas Daniel Dhers (#VEN) y Kenneth Esquivel (#CRC) compitieron con una cinta adhesiva blanca en la parte derecha de sus cascos, la cinta sólo estuvo en la final no en días previos, explicó la razón de esto (hilo)
El casco integral al ser el elemento de mayor importancia tanto en seguridad como fotografía para un ciclista es fabricado a medida por su principal patrocinante donde aprovechan la oportunidad de ocupar el mayor espacio para publicitar su marca, tanto Dhers como Tencio...
Son riders de la reconocida marca Austriaca de bebidas energéticas @redbull, pese a que el reglamento olímpico prohíbe publicitar y nombrar patrocinantes durante el evento, la marca supo hacerla esta vez, metiendo implícitamente su marca en el nombre del país de sus riders...
É DAQUI A POUCO! A GRANDE ABERTURA DOS JOGOS OLÍMPICOS DE VERÃO TÓQUIO 2020!
A partir das 08h, ao vivo na Globo, SporTV e BandSports!
#Tokyo2020 #JogosOlímpicos
A partir das 08h, ao vivo na Globo, SporTV e BandSports!
#Tokyo2020 #JogosOlímpicos
20 MINUTOS! Bruno e Ketleyn já estão no preparo!
📸 Christian Dawes/COB
📸 Christian Dawes/COB
COMEÇOU! FINALMENTE 😭😭😭😭😭
#TumorBoardTuesday
THANK YOU to @KristenCiombor for leading us through a🗣️on pMMR CRC w/ dMMR liver mets
AND thank you for @fireflyann for leading our #PatientExperience 🗣️as well
👉Don’t forget your🆓#CME credit-answer 3 quick❓
Here's the postest🔗
surveymonkey.com/r/DMN786G
THANK YOU to @KristenCiombor for leading us through a🗣️on pMMR CRC w/ dMMR liver mets
AND thank you for @fireflyann for leading our #PatientExperience 🗣️as well
👉Don’t forget your🆓#CME credit-answer 3 quick❓
Here's the postest🔗
surveymonkey.com/r/DMN786G
#TumorBoardTuesday
Thursday Case🎀(Reverse jet-lag edition✈️)
(07/06 and 07/07/21)
We🗣️ #ColorectalCancer and:
✅1st line Tx for dMMR met CRC
✅✔️ing MMR status EVEN in patients with Lynch Syndrome
✅Tumor heterogeneity
We captured the🗣️in this moment:
twitter.com/i/events/14131…
Thursday Case🎀(Reverse jet-lag edition✈️)
(07/06 and 07/07/21)
We🗣️ #ColorectalCancer and:
✅1st line Tx for dMMR met CRC
✅✔️ing MMR status EVEN in patients with Lynch Syndrome
✅Tumor heterogeneity
We captured the🗣️in this moment:
twitter.com/i/events/14131…
#TumorBoardTuesday
Thursday Case🎀
(From 07/06 and 07/07/21)
In the #PatientExperience 🗣️we added:
✅Defining the "lingo", e.g.
👉dMMR = MSI-high
👉pMMR = MS-stable
✅Ensuring tumor testing - and🗣️results w/ docs
✅Scanxiety
Also captured in this moment:
twitter.com/i/events/14132…
Thursday Case🎀
(From 07/06 and 07/07/21)
In the #PatientExperience 🗣️we added:
✅Defining the "lingo", e.g.
👉dMMR = MSI-high
👉pMMR = MS-stable
✅Ensuring tumor testing - and🗣️results w/ docs
✅Scanxiety
Also captured in this moment:
twitter.com/i/events/14132…
Gather around with a snack and ☕️!! We’ll begin with @fireflyann in ≈ 30mins!!
Please share and invite other members of the cancer community!
#TumorBoardTuesday #PatientExperience #ColorectalCancer @MPishvaian @KristenCiombor @Empoweringpts9
Please share and invite other members of the cancer community!
#TumorBoardTuesday #PatientExperience #ColorectalCancer @MPishvaian @KristenCiombor @Empoweringpts9
A couple of reminders.
If you need medical advice, or questions about your treatment or your personal care, please speak with your in-person care team.
#TumorBoardTuesday #PatientExperience #ColorectalCancer #CRC 1/3 @fireflyann
If you need medical advice, or questions about your treatment or your personal care, please speak with your in-person care team.
#TumorBoardTuesday #PatientExperience #ColorectalCancer #CRC 1/3 @fireflyann
Reminder:
Everyone responds to treatment different, please be mindful of other’s experiences.
#TumorBoardTuesday #PatientExperience #ColorectalCancer @fireflyann 2/3
Everyone responds to treatment different, please be mindful of other’s experiences.
#TumorBoardTuesday #PatientExperience #ColorectalCancer @fireflyann 2/3
A short thread about our recent publication on the incorporation of the Convention on the Rights of the Child into national law with @ProfLauraLundy @BronaghByrneQUB @LawUCC @childlawucc @ChildRightsQUB 1/7
States around the world are taking action to give further effect to the Convention on the Rights of the Child in national law, including full incorporation of the #CRC and harmonising law and policy. Our book subjects this trend to international and comparative analysis. 2/7
Writing from national perspectives, from Australia to China, Mexico to Scotland, South Africa to Norway, authors explain the diverse and creative ways in which states have implemented and incorporated the #CRC giving children's rights real force and meaning at national level 3/7
#TumorBoardTuesday
🙏for joining &⚖️in on a robust🗣️ with A LOT of deep🔬on NRG-1 fusion+ #CRC led by @benweinbergmd
➡️Here is this week's Thursday Case🎀
👉👉Don't forget to pick up your🆓#CME credit by answering 2 quick❓
Here is the post-test🔗
bit.ly/3fFpTUe
🙏for joining &⚖️in on a robust🗣️ with A LOT of deep🔬on NRG-1 fusion+ #CRC led by @benweinbergmd
➡️Here is this week's Thursday Case🎀
👉👉Don't forget to pick up your🆓#CME credit by answering 2 quick❓
Here is the post-test🔗
bit.ly/3fFpTUe
#TumorBoardTuesday
Thursday Case🎀
(Case from 04/06/21)
We discussed #colorectalcancer and:
✅ChemoTx choices and sequencing
✅5FU cardiotox
✅KRAS and other🧬alterations
✅And of course all about NRG-1
We captured as much as we could in this moment:
twitter.com/i/events/13794…
Thursday Case🎀
(Case from 04/06/21)
We discussed #colorectalcancer and:
✅ChemoTx choices and sequencing
✅5FU cardiotox
✅KRAS and other🧬alterations
✅And of course all about NRG-1
We captured as much as we could in this moment:
twitter.com/i/events/13794…
#TumorBoardTuesday
Thursday Case🎀
(Case from 04/06/21)
@benweinbergmd presented a case of a patient with met #CRC
👍2-dary🗣️on:
➡️What chemo after metastasectomy
➡️💪evidence for FOLFOXIRI+mAb for metCRC
ncbi.nlm.nih.gov/pubmed/17470860
ncbi.nlm.nih.gov/pubmed/16508637
ncbi.nlm.nih.gov/pubmed/26338525
Thursday Case🎀
(Case from 04/06/21)
@benweinbergmd presented a case of a patient with met #CRC
👍2-dary🗣️on:
➡️What chemo after metastasectomy
➡️💪evidence for FOLFOXIRI+mAb for metCRC
ncbi.nlm.nih.gov/pubmed/17470860
ncbi.nlm.nih.gov/pubmed/16508637
ncbi.nlm.nih.gov/pubmed/26338525
#JPM2021 $GH #GuardantHealth my highlights: jpmorgan.metameetings.net/events/healthc… #LiquidBiopsy they are at the forefront of #Epigenomic profiling (Methylation+Fragmentomics)
#LUNAR1 #CRC bringing #Epigenomic profiling to recurrence testing with #Methylation profiling (no fragmentomics?)
Folks! We return for #HOTrainees with the exciting #Day2 @myESMO #ESMO20 and some more #practice relevant studies in #breastcancer #ProstateCancer #lungcancer #GI, so sit back, relax and lets go through some data (#HO #trainee-style!) Shout out to @peters_solange @OncoAlert
1. #BreastCancer: We have #monarchE and #IMPassion031 hoping to hear from experts @ErikaHamilton9 @NicoleKuderer @DrSGraff @matteolambe @tmprowell @GeorgeSledge51 @VukovicPetra for more insights- please link to your discussions here for #trainees:
1. A) #monarchE: use of #abemiciclib in HR+, HER2-,high risk #EBC in addition to endocrine therapy.
Current #SOC: adjuvant ET (5-10 years)
#monarchE: #Abemaciclib + ET iDFS HR 0.747, here's a great summary by @ErikaHamilton9 for @OncoAlert :
Current #SOC: adjuvant ET (5-10 years)
#monarchE: #Abemaciclib + ET iDFS HR 0.747, here's a great summary by @ErikaHamilton9 for @OncoAlert :
So excited for the #NtlMtg20 to kick-off!!!
Ready to hear from @NASPADavid, Aimee, Courtney & so many other amazing people in our field!
Ready to hear from @NASPADavid, Aimee, Courtney & so many other amazing people in our field!
